Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer

NCT00299390 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
10
Enrollment
INDUSTRY
Sponsor class

Stopped Since only 1 of the first 10 subjects responded to the study treatment, it was decided to stop the trial due to lack of efficacy .

Conditions

Interventions

Sponsor

Bayer